(Updates)
** Diagnostic test maker OraSure Technologies Inc's OSUR.O
shares up 7% at $7.55
** Company on Wednesday reported better-than-expected Q1 adj
profit of 37 cents/shr vs est 14 cents/shr - Refinitiv
** Posts Q1 revenue of $154.96 mln vs est $126.57 mln; beat
driven by higher COVID-19 rapid test volumes on U.S. government
orders
** Q2 revenue forecast of $62 mln to $67 mln below est
$94.67 mln
** Company anticipates experiencing some temporary margin
headwinds in Q2 2023 due to pricing mix of its COVID-19 rapid
test
** OraSure earlier in the year reduced 11% of its
non-production workforce expecting expense reduction of about
$15 mln annually
** Jefferies raises PT on company's shares to $6.75 from
$5.50; brokerage, however, maintains "hold" rating
** Including session's gain, stock up 56.5% YTD
(Reporting by Pratik Jain in Bengaluru)
((Pratik.Jain@thomsonreuters.com))